| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7613 |
| Human Intestinal Absorption | HIA+ | 0.9778 |
| Caco-2 Permeability | Caco2+ | 0.8590 |
| P-glycoprotein Substrate | Non-substrate | 0.7474 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9876 |
| Non-inhibitor | 0.9964 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9156 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8921 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8026 |
| CYP450 2D6 Substrate | Non-substrate | 0.9179 |
| CYP450 3A4 Substrate | Non-substrate | 0.7104 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8410 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7510 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9291 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8807 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8276 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7852 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9494 |
| Non-inhibitor | 0.9720 |
| AMES Toxicity | Non AMES toxic | 0.9472 |
| Carcinogens | Non-carcinogens | 0.8100 |
| Fish Toxicity | High FHMT | 0.9124 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8330 |
| Honey Bee Toxicity | High HBT | 0.7124 |
| Biodegradation | Not ready biodegradable | 0.8104 |
| Acute Oral Toxicity | III | 0.6398 |
| Carcinogenicity (Three-class) | Non-required | 0.6719 |